PATENT CLAIM ANALYSIS

Application Number: 15910517
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "006160"]

Abstract:
The present invention relates to methods of treating neurodegenerative disorders associated with Alzheimer's disease (AD), Parkinson's disease (PD) and synucleinopathies, such as dementia with Lewy bodies, Down Syndrome (DS) and associated cognitive disorders, multiple system atrophy, and rare neuroaxonal dystrophies, such as Niemann-Pick type C disease (NPC) and Gaucher's disease comprising administering an inhibitor to disrupt the interaction between Aβ or αS and neuronal lipids. The invention further relates to assays for identifying agents that reduce interaction between Aβ or αS and neuronal lipids. Lastly, the invention relates to methods and compositions for intranasal administration of fatty acids or lipids containing fatty acid acyl chains of dietary lipids for promoting central nervous system health and/or prevention or treatment of neurodegenerative disorders.

Claim (Index 24):
A pharmaceutical composition for treating a subject in need thereof, comprising a therapeutically effective amount of one or more lipid, where said composition is administered to a subject intranasally to promote central nervous system health.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.73171
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11516224', '12386140', '13456691', '12244968', '11637607']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.611134436905065
- 35 USC 102 Novelty (BERT): 0.5157265602306079
- Combined Prediction Score: 0.6015936492376193
- Mean Citation Score: 264.88296
- Max Citation Score: 295.85107
- Similarity Product: 176.65959221915958

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test